These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9278608)

  • 21. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.
    Ksiazek TG; Rollin PE; Williams AJ; Bressler DS; Martin ML; Swanepoel R; Burt FJ; Leman PA; Khan AS; Rowe AK; Mukunu R; Sanchez A; Peters CJ
    J Infect Dis; 1999 Feb; 179 Suppl 1():S177-87. PubMed ID: 9988182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.
    Bray M; Geisbert TW
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1560-6. PubMed ID: 15896665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams.
    Breman JG; Johnson KM; van der Groen G; Robbins CB; Szczeniowski MV; Ruti K; Webb PA; Meier F; Heymann DL
    J Infect Dis; 1999 Feb; 179 Suppl 1():S139-47. PubMed ID: 9988177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus.
    Bray M; Hatfill S; Hensley L; Huggins JW
    J Comp Pathol; 2001 Nov; 125(4):243-53. PubMed ID: 11798241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.
    Jankeel A; Menicucci AR; Woolsey C; Fenton KA; Mendoza N; Versteeg K; Cross RW; Geisbert TW; Messaoudi I
    J Virol; 2020 May; 94(11):. PubMed ID: 32213610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston).
    Morikawa S; Saijo M; Kurane I
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):391-8. PubMed ID: 17610952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Search for the Ebola virus reservoir in Kikwit, Democratic Republic of the Congo: reflections on a vertebrate collection.
    Leirs H; Mills JN; Krebs JW; Childs JE; Akaibe D; Woollen N; Ludwig G; Peters CJ; Ksiazek TG
    J Infect Dis; 1999 Feb; 179 Suppl 1():S155-63. PubMed ID: 9988179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.
    Jones SM; Stroher U; Fernando L; Qiu X; Alimonti J; Melito P; Bray M; Klenk HD; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S404-12. PubMed ID: 17940977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996.
    Miranda ME; Ksiazek TG; Retuya TJ; Khan AS; Sanchez A; Fulhorst CF; Rollin PE; Calaor AB; Manalo DL; Roces MC; Dayrit MM; Peters CJ
    J Infect Dis; 1999 Feb; 179 Suppl 1():S115-9. PubMed ID: 9988174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002].
    Nkoghe D; Formenty P; Leroy EM; Nnegue S; Edou SY; Ba JI; Allarangar Y; Cabore J; Bachy C; Andraghetti R; de Benoist AC; Galanis E; Rose A; Bausch D; Reynolds M; Rollin P; Choueibou C; Shongo R; Gergonne B; Koné LM; Yada A; Roth C; Mve MT
    Bull Soc Pathol Exot; 2005 Sep; 98(3):224-9. PubMed ID: 16267965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ebola Reston virus infection of pigs: clinical significance and transmission potential.
    Marsh GA; Haining J; Robinson R; Foord A; Yamada M; Barr JA; Payne J; White J; Yu M; Bingham J; Rollin PE; Nichol ST; Wang LF; Middleton D
    J Infect Dis; 2011 Nov; 204 Suppl 3():S804-9. PubMed ID: 21987755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Ebola virus transmission events and rapid decline of central African wildlife.
    Leroy EM; Rouquet P; Formenty P; Souquière S; Kilbourne A; Froment JM; Bermejo M; Smit S; Karesh W; Swanepoel R; Zaki SR; Rollin PE
    Science; 2004 Jan; 303(5656):387-90. PubMed ID: 14726594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs.
    Kobinger GP; Leung A; Neufeld J; Richardson JS; Falzarano D; Smith G; Tierney K; Patel A; Weingartl HM
    J Infect Dis; 2011 Jul; 204(2):200-8. PubMed ID: 21571728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
    Geisbert TW; Hensley LE; Geisbert JB; Jahrling PB
    Virology; 2002 Feb; 293(1):15-9. PubMed ID: 11853394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin G enzyme-linked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus.
    Ikegami T; Saijo M; Niikura M; Miranda ME; Calaor AB; Hernandez M; Manalo DL; Kurane I; Yoshikawa Y; Morikawa S
    Epidemiol Infect; 2003 Jun; 130(3):533-9. PubMed ID: 12825739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus.
    Gupta M; Goldsmith CS; Metcalfe MG; Spiropoulou CF; Rollin PE
    Virology; 2010 Jun; 402(1):203-8. PubMed ID: 20394957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ebola virus defective interfering particles and persistent infection.
    Calain P; Monroe MC; Nichol ST
    Virology; 1999 Sep; 262(1):114-28. PubMed ID: 10489346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model.
    Huggins J; Zhang ZX; Bray M
    J Infect Dis; 1999 Feb; 179 Suppl 1():S240-7. PubMed ID: 9988190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.